These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24959733)

  • 1. Whole-body phenylalanine kinetics and skeletal muscle protein signaling in horses with pituitary pars intermedia dysfunction.
    Mastro LM; Adams AA; Urschel KL
    Am J Vet Res; 2014 Jul; 75(7):658-67. PubMed ID: 24959733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary pars intermedia dysfunction does not necessarily impair insulin sensitivity in old horses.
    Mastro LM; Adams AA; Urschel KL
    Domest Anim Endocrinol; 2015 Jan; 50():14-25. PubMed ID: 25240230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
    Rendle DI; Litchfield E; Heller J; Hughes KJ
    Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction.
    McFarlane D; Holbrook TC
    J Vet Intern Med; 2008; 22(2):436-42. PubMed ID: 18371032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
    Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
    Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
    Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
    Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
    Beech J; Boston RC; McFarlane D; Lindborg S
    J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tissue-specific cortisol activity with regard to degeneration of the suspensory ligaments in horses with pituitary pars intermedia dysfunction.
    Hofberger SC; Gauff F; Thaller D; Morgan R; Keen JA; Licka TF
    Am J Vet Res; 2018 Feb; 79(2):199-210. PubMed ID: 29359976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunction.
    Aleman M; Nieto JE
    Am J Vet Res; 2010 Jun; 71(6):664-70. PubMed ID: 20513182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction.
    Frank N; Elliott SB; Chameroy KA; Tóth F; Chumbler NS; McClamroch R
    J Vet Intern Med; 2010; 24(5):1167-75. PubMed ID: 20666984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of inflamm-aging with circulating nutrient levels, body composition, age, and pituitary pars intermedia dysfunction in a senior horse population.
    Siard-Altman MH; Harris PA; Moffett-Krotky AD; Ireland JL; Betancourt A; Barker VD; McMurry KE; Reedy SE; Adams AA
    Vet Immunol Immunopathol; 2020 Mar; 221():110013. PubMed ID: 32058159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
    Horn R; Bertin FR
    J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
    Copas VE; Durham AE
    Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
    Lee ZY; Zylstra R; Haritou SJ
    Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
    Beech J; Boston R; Lindborg S
    J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
    Knowles EJ; Menzies-Gow NJ; Mair TS
    Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction.
    Pease AP; Schott HC; Howey EB; Patterson JS
    J Vet Intern Med; 2011; 25(5):1144-51. PubMed ID: 21985144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal glucose metabolism and peripheral insulin sensitivity in equine pituitary pars intermedia dysfunction.
    Klinkhamer K; Menheere PP; van der Kolk JH
    Vet Q; 2011 Mar; 31(1):19-28. PubMed ID: 22029818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.